Table 4. Summary of Empirical Studies Referenced.
Sampling schema and results from empirical studies that reported the number of intra-host SNPs identified in patient samples. Note that all studies apart from Lythgoe et al. 2021 utilized serial sampling within at least one patient during their data collection; this did not impact their reported number of intra-host SNPs, but did allow for confirmation of SNPs as true positives.
| Paper | Time to Sample | MAF Filter | Intra-host SNPs |
|---|---|---|---|
| Lythgoe et al. 2021 | “symptomatic individuals on admission to the hospital” | 3% | 1.4 (mean) |
| Valesano et al. 2021 | −7 to 20 days post symptom onset | 2% | 1 (median); 0–2 (IQR) |
| Wang et al. 2021 | 10 to 37 days post-symptom onset (18.09 days (mean)) | 5% | 7.33 (mean); 1–23 (Range) |
| Bendall et al. 2023 | Symptoms and positive test within 7 days | 2%* | ~0.82 (mean); 0–5 (Range) |
| Gu et al. 2023 | With 5 days of symptom onset (2.3 days (mean)) | 2.50% | 10.05 (mean); 5 (median) |
Intra-host SNP had to clear MAF filter in two technical replicates